Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

1446089-82-2

N-Desmethyl-N-benzyl Sildenafil

1446089-82-2
1695-77-8

Spectinomycin HCl

1695-77-8
139-05-9

Sodium Cyclamate

139-05-9
57-24-9

Strychnine

57-24-9
23312-56-3

Spectinomycin sulfate

23312-56-3
341031-54-7

Sunitinib Malate

341031-54-7
356068-99-0

Sunitinib N-Oxide

356068-99-0
122-16-7

Sulfanitran

122-16-7
102-65-8

Sulfachloropyrazine sodium monohydrate

102-65-8
24730-31-2

Surfactin

24730-31-2
65666-07-1

Silymarin

65666-07-1
65-45-2

Salicylamide

65-45-2
334-50-9

Spermidine 3HCl

334-50-9
22199-08-2

Silver Sulfadiazine

22199-08-2
18179-67-4

Sulfameter sodium salt

18179-67-4
1069-66-5

Sodium valproate

1069-66-5
99592-39-9

Sertaconazole nitrate

99592-39-9
142797-34-0

Silybin B

142797-34-0
33889-69-9

Silychristin

33889-69-9
29782-68-1

Silydianin

29782-68-1